Cover Image

Molecular Docking and Dynamics Simulations Reveal the Potential of Anti-HCV Drugs to Inhibit COVID-19 Main Protease

Background: Drug repurposing is the fastest effective method to provide treatment for coronavirus disease (COVID-19). Drugs that targeting a closely related virus with similar genetic material such as hepatitis C virus (HCV) and more specifically targeting a similar viral protease would be an excell...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ahmed Ali Al-Karmalawy (Author), Radwan Alnajjar (Author), Mohammed Dahab (Author), Ahmed Metwaly (Author), Ibrahim Eissa (Author)
Format:	Book
Published:	Tabriz University of Medical Sciences, 2021-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Molecular docking and dynamic simulations study for repurposing of multitarget coumarins against SARS-CoV-2 main protease, papain-like protease and RNA-dependent RNA polymerase
by: Mai E. Shoman, et al.
Published: (2022)

Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations
by: Mehdi Oubahmane, et al.
Published: (2023)

Molecular docking study and molecular dynamics simulation of spice metabolites against main protease enzymes and NSP3 macrodomain SARS CoV-2
by: Purwaniati Purwaniati, et al.
Published: (2022)

Exploring Toxins for Hunting SARS-CoV-2 Main Protease Inhibitors: Molecular Docking, Molecular Dynamics, Pharmacokinetic Properties, and Reactome Study
by: Mahmoud A. A. Ibrahim, et al.
Published: (2022)

In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing
by: Yogesh Kumar, et al.
Published: (2020)

Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studies
by: Faten Farouk, et al.
Published: (2023)

Comparison of COVID-19 Virus Main Protease Inhibition Activities of Phenolic Acids By Molecular Docking
by: Razie Sabet, et al.
Published: (2021)

Chlorhexidine and SARS-CoV-2 main protease: Molecular docking study
by: Vishakha Grover, et al.
Published: (2022)

Design, synthesis, docking, MD simulations, and anti-proliferative evaluation of thieno[2,3-d]pyrimidine derivatives as new EGFR inhibitors
by: Eman A. Sobh, et al.
Published: (2023)

In Silico Prediction of Novel Inhibitors of SARS-CoV-2 Main Protease through Structure-Based Virtual Screening and Molecular Dynamic Simulation
by: Sobia Ahsan Halim, et al.
Published: (2021)

QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease
by: Fucheng Song, et al.
Published: (2023)

Natural Products as Inhibitors of COVID-19 Main Protease - A Virtual Screening by Molecular Docking
by: Marzieh Omrani, et al.
Published: (2021)

Docking and Dynamics Study of Phytochemicals as Potent Inhibitors against SARS-CoV-2 Main Protease
by: Palla Ramprasad, et al.
Published: (2022)

Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking
by: Xinbo Yang, et al.
Published: (2022)

Molecular Docking of Novel 5-O-benzoylpinostrobin Derivatives as SARS-CoV-2 Main Protease Inhibitors
by: Mohammad Rizki Fadhil Pratama, et al.
Published: (2020)

Docking Study of Naringin Binding with COVID-19 Main Protease Enzyme
by: Narmin H. Amin Huseen
Published: (2020)

Potential of plant alkaloids as dengue ns3 protease inhibitors: Molecular docking and simulation approach
by: Muhammad Tahir ul Qamar, et al.
Published: (2014)

Potential of plant alkaloids as dengue NS3 protease inhibitors: Molecular docking and simulation approach
by: Muhammad Tahir ul Qamar, et al.
Published: (2014)

Inhibition of acetylcholinesterase by two genistein derivatives: kinetic analysis, molecular docking and molecular dynamics simulation
by: Jiansong Fang, et al.
Published: (2014)

Repurposing of Oxicam Derivatives to Inhibit NDM-1: Molecular Docking and Molecular Dynamic Simulation Studies
by: Pshtiwan Gharib Ali, et al.
Published: (2024)

Structure dynamics and solvation of HIV-1 protease wildtype complexed with inhibitors by molecular dynamic simulations
by: Kitiyaporn Wittayanarakul
Published: (2014)

Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis
by: Jiawei Liu, et al.
Published: (2022)

Investigation of phytochemicals isolated from selected Saudi medicinal plants as natural inhibitors of SARS CoV-2 main protease: In vitro, molecular docking and simulation analysis
by: Yousef T.M. Alharbi, et al.
Published: (2024)

Prediction of Asiatic Acid Derivatives Affinity Against SARS-CoV-2 Main Protease Using Molecular Docking
by: Ida Musfiroh, et al.
Published: (2020)

Identification of Potential Flavonoid Inhibitors of the SARS-CoV-2 Main Protease 6YNQ: A Molecular Docking Study
by: Sumit Arora, et al.
Published: (2020)

Potential anti-colon cancer agents: Molecular modelling, docking, pharmacokinetics studies and molecular dynamic simulations
by: Auwal Salisu Isa, et al.
Published: (2024)

Molecular Docking and Molecular Dynamics
Published: (2019)

POTENSI DAUN TEH HIJAU (Camellia sinensis) SEBAGAI INHIBITOR MAIN PROTEASE (Mpro) COVID-19: SEBUAH STUDI MOLECULAR DOCKING
by: Haidar Ali Hamzah, et al.
Published: (2022)

New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studies
by: Eslam B. Elkaeed, et al.
Published: (2022)

Molecular Dynamic Simulation and Docking of Cyclophilin A Mutants with its Potential Inhibitors
by: Alireza Mohebbi, et al.
Published: (2021)

POTENSI DAUN TEH HIJAU (Camellia sinensis) SEBAGAI INHIBITOR MAIN PROTEASE (Mpro) COVID-19: SEBUAH STUDI MOLECULAR DOCKINGPOTENSI DAUN TEH HIJAU (Camellia sinensis) SEBAGAI INHIBITOR MAIN PROTEASE (Mpro) COVID-19: SEBUAH STUDI MOLECULAR DOCKING
by: Haidar Ali Hamzah, et al.
Published: (2022)

Molecular docking analysis of peptide-based antiviral agents against SARS-CoV-2 main protease: an approach towards drug repurposing
by: Abhishek Chaurasiya, et al.
Published: (2023)

Inhibitory effect of lupeol, quercetin, and solasodine on Rhizopus oryzae: A molecular docking and dynamic simulation study
by: Deepavalli Arumuganainar, et al.
Published: (2023)

Discovery of new nicotinamides as apoptotic VEGFR-2 inhibitors: virtual screening, synthesis, anti-proliferative, immunomodulatory, ADMET, toxicity, and molecular dynamic simulation studies
by: Reda G. Yousef, et al.
Published: (2022)

In-silico study MM/GBSA binding free energy and molecular dynamics simulation of some designed remdesivir derivatives as the inhibitory potential of SARS-CoV-2 main protease
by: Maryam Abbasi, et al.
Published: (2024)

Molecular Docking and Molecular Dynamics Simulation using Monascus sp. as a Candidate Cervical Cancer Drug
by: Anna Yuliana, et al.
Published: (2023)

Synthesis, Molecular Docking, Molecular Dynamic Simulation Studies, and Antitubercular Activity Evaluation of Substituted Benzimidazole Derivatives
by: Shankar Thapa, et al.
Published: (2024)

Potential Antidiabetic Compounds from Anogeissus leiocarpus: Molecular Docking, Molecular Dynamic Simulation, and ADMET Studies
by: Mubarak Muhammad Dahiru, et al.
Published: (2023)

Potential Antidiabetic Compounds from Anogeissus leiocarpus: Molecular Docking, Molecular Dynamic Simulation, and ADMET Studies
by: Mubarak Muhammad Dahiru, et al.
Published: (2023)

Discovery of Novel and Highly Potent Inhibitors of SARS CoV-2 Papain-Like Protease Through Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, Molecular Dynamics Simulations, and Biological Evaluation
by: Xiaoyan Tian, et al.
Published: (2022)